Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

ESMO Open

Topics

Medicine

Cancer Oncology

Internal Medicine

Urology

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.1016/j.esmoop.2024.104085